Skip to main content
. 2023 Feb 2;14:1113932. doi: 10.3389/fimmu.2023.1113932

Table 2.

SARS-CoV-2 RBD and N ELISA reactivity.

Non-Severe COVID-19
(n=14)
Severe COVID-19 (n=13) COVID Recovered (n=5) Healthy controls (n=4)
RBD Reactive 78.6% (11) 100% (13) 80.0% (4) 0% (0)
N Reactive 64.3% (9) 84.6% (11) 80.0% (4) 0% (0)
RBD and N Reactive 64.3% (9/14) 84.6% (11/13) 80.0% (4/5) 0% (0/4)
Only RBD Reactive 14.3% (2/14) 15.4% (2/13) 0% (0/5) 0% (0/4)
RBD and N Non-reactive 21.4% (3/14) 0% (0/13) 20% (1/5) 100% (4/4)